iSpecimen (ISPC) Notes Payables (2020 - 2024)

iSpecimen (ISPC) posted quarterly Notes Payables of $864425.0 for Q3 2024, up 5.85% quarter-over-quarter from $816667.0 in Q3 2022.

iSpecimen (ISPC) Notes Payables (2020 - 2024) Analysis & Trends

iSpecimen's Notes Payables history runs 3 years deep, the most recent figure standing at $864425.0 for Q3 2024.

In Q3 2024, Notes Payables changed N/A year-over-year to $864425.0; the TTM figure through Sep 2024 stood at $864425.0 (changed N/A YoY), while the FY2020 annual figure was $2.4 million, changed N/A from the prior year.
Notes Payables for Q3 2024 stood at $864425.0, up from $816667.0 in the prior quarter.
The five-year high for Notes Payables was $2.4 million in Q4 2020, with the low at $466667.0 in Q2 2022.
The 3-year median for Notes Payables is $840546.0 (2022), against an average of $1.1 million.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	iSpecimen	2.25 Mn	-2.16 Mn	68,650.00

Download Data